Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
54,531 views
0 likes
|
Last Post
by Guest
11-06-2019, 05:43 AM
|
||
Started by VincentC, 09-10-2013, 02:24 AM
|
1 response
1,426 views
0 likes
|
Last Post
by RebeccaUNIGE
09-10-2013, 02:32 AM
|
||
Started by Diz, 09-08-2013, 09:58 AM
|
0 responses
1,316 views
0 likes
|
Last Post
by Diz
09-08-2013, 09:58 AM
|
||
Started by seqador, 08-06-2013, 09:01 AM
|
1 response
1,890 views
0 likes
|
Last Post
by Melissa
09-08-2013, 08:49 AM
|
||
Started by abilslan, 09-06-2013, 04:13 PM
|
5 responses
3,485 views
0 likes
|
Last Post
by abilslan
09-07-2013, 09:28 AM
|
||
Started by Shivangi, 09-06-2013, 03:28 AM
|
1 response
1,738 views
0 likes
|
Last Post
by Shishir
09-06-2013, 03:34 AM
|
||
HI
by chhavi.dawar
Started by chhavi.dawar, 09-03-2013, 09:12 PM
|
0 responses
1,669 views
0 likes
|
Last Post
by chhavi.dawar
09-03-2013, 09:12 PM
|
||
Started by Leochong718, 09-03-2013, 03:44 PM
|
0 responses
1,750 views
0 likes
|
Last Post
by Leochong718
09-03-2013, 03:44 PM
|
||
Hola hola!
by xavi6
Started by xavi6, 09-03-2013, 03:10 AM
|
0 responses
1,648 views
0 likes
|
Last Post
by xavi6
09-03-2013, 03:10 AM
|
||
Started by francesca77, 09-02-2013, 05:47 AM
|
0 responses
1,529 views
0 likes
|
Last Post
by francesca77
09-02-2013, 05:47 AM
|
||
Started by gberan, 09-02-2013, 05:45 AM
|
0 responses
1,619 views
0 likes
|
Last Post
by gberan
09-02-2013, 05:45 AM
|
No topics found.
-
Page of 0
-
Filter
Webinars
Collapse
-
by seqadminJoin us for our insightful SEQanswers webinar "Harnessing NGS in Cancer Research." This session will feature a panel of scientists discussing...
-
Channel: Webinar Series
03-18-2024, 08:22 AM -
Recent Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
-
by seqadmin
The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.
Avian Conservation
Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...-
Channel: Articles
03-08-2024, 10:41 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
27 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
30 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
26 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|